Overview
Stops your body from burning through its own energy fuel so fat-burning runs more efficiently.
What It Does
Blocks NNMT enzyme to support fat metabolism, cellular energy, and NAD+ preservation.
Inhibits Nicotinamide N-methyltransferase (NNMT), reducing NAD+ consumption and increasing SIRT1/AMPK activity.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 5 mg | + 0.25 mL | 20 mg/mL |
| 10 mg | + 0.50 mL | 20 mg/mL |
| 50 mg | + 2.5 mL | 20 mg/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Weeks 1– | Daily AM | 2.5 | Tolerance check. SC abdomen or thigh. Assess GI tolerance and stimulation before stepping up. |
| Weeks 3– | Daily or twice | 5 mg | Working dose. Half-life 3.8–6.9 h, so splitting into two daily doses gives steadier NNMT inhibition. Hold here if Weeks 1–2 |
| Off | 4 weeks | – | Standard |
8 weeks on, 4 weeks off. Extended: 12 on, 6 off. Cycle: 6–8 weeks on, 2–4 weeks off.
AM only, stimulating; avoid evening doses (sleep disruption).
Unisex metabolic (NNMT inhibitor), same protocol for men and women, no cycle effect.
Handling & Stacking
- Freeze-dried: -4°F (up to 24 months).
- Reconstituted: 36–46°F.
- Best used within 28 days for sterility; the molecule itself stays stable well beyond that (small molecule, not a fragile peptide).
- No freeze-thaw.
- Mild appetite suppression and slight stimulation within 1–2 hours.
- Fat loss is gradual, most noticeable at 6–8 weeks with consistent caloric deficit.
- Supply math 5mg → 49 vials | 10mg → 25 vials | 50mg → 5 vials (8-wk @ 5 mg × 7/wk)
Safety & Patient Education
- Compound-specific: Fasting glucose + HbA1c (baseline + end), lipid panel (Week 0/12), Out of range?
- Rising glucose/HbA1c = blood sugar creeping up (recheck, adjust diet); worsening lipids = reassess the fat-loss protocol.
